By Sola Charles
With antibiotic use in livestock projected to rise by nearly 30 per cent by 2040, global health experts have warned that antimicrobial resistance (AMR) could become an even greater threat to human survival, food security and the environment unless governments move beyond policy commitments to urgent, coordinated action.
The experts warned that the growing misuse and overuse of antimicrobials, coupled with poor infection prevention, environmental pollution, weak surveillance and inadequate regulation, are accelerating the emergence and spread of drug-resistant infections that could undermine decades of medical and agricultural progress.
They called for governments to strengthen national AMR action plans, invest in surveillance and laboratory systems, regulate antimicrobial use in humans, animals and agriculture, and tackle pollution from pharmaceutical manufacturing, healthcare facilities and municipal wastewater systems.
The warning comes ahead of the 2026 World AMR Awareness Week (WAAW) November 18 to 24, with the theme, “One Health, One Action: Prevent AMR Now.”
Director (a.i.) of the Antimicrobial Resistance Department of the World Health Organisation (WHO) and Director of the Quadripartite Joint Secretariat on AMR, Dr Jean-Pierre Nyemazi, said: “AMR is one of the most urgent global health threats and development challenges. It threatens our ability to treat infections, protect animal and plant health, and produce safe food, and also has an impact on the environment.
“In 2021, bacterial AMR alone was associated with more than 4.7 million deaths, these are not just statistics, behind these numbers are patients, families, farmers and communities.
“AMR does not recognize borders or sectors. It is driven by the misuse and overuse of antimicrobials. It is also driven by gaps in infection prevention and control, poor water and sanitation, and contamination in the environment. Action in one sector affects all others,” Nyemazi said.
He said world leaders had already made commitments at the 2024 United Nations General Assembly High-Level Meeting on AMR, including a target to reduce deaths associated with bacterial AMR by 10 per cent by 2030, against the 2019 baseline of 4.95 million deaths.
Countries also committed to ensuring that at least 60 per cent had funded national action plans on AMR, alongside mobilisation of at least $100 million in catalytic funding to support implementation.
“However, let’s be honest. The gap between commitments and pledges versus implementation remains wide. Many countries face limited financing, fragmented coordination across sectors, and also weak surveillance and data systems, in addition to poor access or inappropriate use of antimicrobials across all the sectors,” he said.
Nyemazi disclosed that an updated Global Action Plan on AMR, covering 2026 to 2036, had been finalised to guide the next decade of interventions.
He also announced that the Fifth Global High-Level Ministerial Conference on AMR would hold in Abuja, Nigeria, from December 6 to 8, 2026, under the theme, “One Health: Advancing Global AMR Commitments through Local Action.”
The conference is expected to review global progress, address implementation gaps and renew political commitment, while the proposed Independent Panel on Evidence for Action against AMR is also expected to be launched.
Livestock antibiotics could rise 30%
Reinforcing the warning, Deputy Chief Veterinarian and Chief of the One Health and Disease Control Branch at the Food and Agriculture Organisation of the United Nations (FAO), Dr Junxia Song, said the agri-food sector must become a central part of the global response, warning that rising antibiotic consumption in livestock could worsen the resistance crisis.
"The urgency is clear. FAO’s recent study, ‘The Future of Antibiotics Use in Livestock,’ shows that without action, global antibiotic use in livestock could increase by nearly 30 percent by 2040. But with good practices on better animal health and better practices on farm management, antibiotic use could be reduced up to 57 percent. This is the power of prevention.
“We must reduce the need for antibiotics while ensuring effective antimicrobials remain available and are used responsibly when treatment is necessary,” she said.
Song said FAO's 2026 to 2036 AMR roadmap would translate global commitments into practical interventions across the agri-food system, with emphasis on stronger national action plans, prevention, surveillance, laboratory capacity and sustainable financing.
She, however, identified inadequate integration of agricultural priorities into national AMR plans as a major weakness, noting that nearly half of countries had either no legislation or only partial legislation governing antimicrobial use in animal and plant health.
According to her, farmers must be placed at the centre of the response through FAO's 10-year initiative, Reduce the Need for Antimicrobials on Farms (RENOFARM).
The initiative is built around five interconnected areas: good health services, good production practices, good alternatives and innovation, good incentives and good connections, collectively described as the 5G farm approach.
More than 400 partners, including over 80 FAO Member Countries, individual experts and international and regional organisations, were already engaged in the initiative.
“Better data can help countries understand their national situation, strengthen policies and regulations, and direct limited resources where they can have the greatest impact.
“Awareness and commitments are important, but they are not enough. Countries and farmers need stronger services, incentives, financing and capacity. So, our solutions must be practical, affordable and rewarding for farmers,” she noted.
Pollution is fuelling resistance
Adding an environmental dimension to the warning, AMR Coordinator, Chemicals and Health Branch, United Nations Environment Programme (UNEP), Aitziber Echeverria, cautioned that efforts to tackle drug resistance would remain incomplete if governments continued to treat it exclusively as a human health and agricultural problem.
She said the environment plays a significant role in the emergence, transmission and spread of antimicrobial resistance, with antimicrobial residues, resistant microorganisms and resistance genes entering ecosystems through pollution.
“AMR is often discussed as a public health and agriculture challenge — which of course it is, and a major one — but it is an environmental issue too,” she said.
Referring to UNEP's report, Bracing for Superbugs: Strengthening Environmental Action in the One Health Response, Echeverria said the environmental dimension of AMR must be addressed as an integral part of the global response.
According to her, pharmaceutical manufacturing must reduce the discharge of antimicrobial residues, while more sustainable agricultural practices can limit pollution from animal and crop production.
Healthcare facilities also need stronger antimicrobial stewardship, while municipal authorities must address untreated or inadequately treated waste and wastewater that can create conditions for resistance to emerge and spread.
She said preventing pollution at its source was critical, warning that environmental contamination could undermine gains made through interventions in human and animal health.
“All this brings us to stress that the most urgent action is prevention. We need to reduce the release of antimicrobial residues, resistant microorganisms and genes into the environment before they become a challenge. This means tackling pollution at its source — upstream,” she said.
Echeverria described the December 2025 adoption of a United Nations Environment Assembly resolution on the environmental dimensions of AMR as a significant milestone, but stressed that countries must now translate policy recognition into funded interventions.
She called for stronger environmental monitoring and surveillance systems, explaining that environmental data could help identify AMR hotspots and sources of contamination before they become more serious threats.
She also urged governments to formally include environmental authorities and institutions in national AMR governance structures rather than treating them as peripheral stakeholders.
“Too often they do not play an active role and environmental expertise is brought in only later,” she said.
According to her, environmental objectives and indicators must be incorporated into national AMR action plans and backed by adequate financing.
Making a strong case for integrated action, Echeverria warned that environmental interventions were not optional additions to the global response.
“Environmental action on AMR is not an optional addition to the response. It is a prerequisite for success in addressing AMR with One Health approach. If we do not address the environmental dimensions of AMR, we risk undermining efforts in human and animal health.”
She added that tackling environmental drivers of AMR would also deliver wider benefits, including improved public health, biodiversity protection, water security and progress against climate change, nature loss and pollution.
Her position was that countries must stop treating human health, animal health, agriculture and the environment as separate policy concerns.
### AMR: WHO, WOAH warn of widening implementation gaps, call for urgent investment in prevention
By Sola Ogundipe
The fight against antimicrobial resistance (AMR) risks losing ground unless countries move beyond political commitments to adequately fund prevention, strengthen surveillance, expand laboratory capacity and ensure responsible use of medicines across human, animal and environmental health, experts have warned.
They said the growing threat of drug-resistant infections requires urgent action across sectors, warning that weak health systems, inadequate financing, poor disease prevention and inappropriate antimicrobial use are undermining efforts to contain a crisis that threatens lives, food security and livelihoods.
With the updated Global Action Plan on Antimicrobial Resistance 2026–2036 setting a new framework for the next decade, experts say the challenge is now to translate international commitments into measurable results at country level.
The warning comes ahead of the Fifth Global High-Level Ministerial Conference on AMR in Abuja next month, where governments and international partners are expected to renew commitments to tackling antimicrobial resistance.
Speaking on the implementation challenges, Dr Kefas Samson, Senior Technical Officer and Lead of Multisectoral Coordination, AMR Department, World Health Organisation (WHO) headquarters, said although political commitment had strengthened considerably, countries were still struggling with the resources and systems needed to deliver results.
Samson said the WHO, through the Quadripartite Joint Secretariat on AMR, was working with the Food and Agriculture Organisation (FAO), United Nations Environment Programme (UNEP) and World Organisation for Animal Health (WOAH) to help countries translate global commitments into practical interventions.
He said: “In terms of priorities and implementation gaps for WHO: evidently, to ensure that countries can effectively translate these global commitments into action, the focus of WHO is also on ensuring that these countries are able to assess their needs, prioritize and cost their interventions, and tailor implementations to their local realities and available resources as well.”
He identified inadequate financing, weak nationwide surveillance, poor diagnostic capacity and limited access to quality-assured antimicrobials as major obstacles slowing progress.
“Significant gaps still persist, and progress among countries also remains uneven. Notable among those challenges include inadequate financing to actually support the desired level of acceleration of implementation; gaps in nationwide implementation of AMR and antimicrobial use surveillance; as well as in the institution of preventive measures, particularly in healthcare facilities.
“There is also the issue of inadequate diagnostic capacity to support treatment decisions, as well as gaps in access to quality-assured antimicrobials, which is really a key issue. These gaps are also compounded by shortage of healthcare workforce, just like in other sectors, and inequitable access to the products that are required to support clinical activities.”
Beyond hospitals and specialist health facilities, Samson said primary healthcare and community-based services must become central to the AMR response, particularly in preventing infections, promoting behavioural change, improving early diagnosis and ensuring appropriate treatment.
He explained that the updated Global Action Plan 2026–2036 was designed to move countries from broad commitments to measurable implementation, with stronger emphasis on One Health collaboration, prevention, surveillance, research, innovation and sustainable financing.
“The Global Action Plan on AMR 2026-2036 provides a renewed blueprint for accelerating the implementation of actions to address the AMR issue but also being more measurable in terms of how impact and outcomes are intended to be measured. It is not just a plan now; but a framework that translates the aspirations and ambitions of the political declaration on AMR 2024 into tangible actions at the country level.”
According to him, the plan also seeks to strengthen laboratory capacity, improve access to essential antimicrobials and promote responsible use, while addressing weaknesses in supply chains and governance.
He said WHO was working towards the 2030 targets, including ensuring that 70 per cent of antibiotics used in the human health sector belong to the WHO Access group and that 80 per cent of countries can test for priority bacterial and fungal pathogens under the WHO Global Antimicrobial Resistance and Use Surveillance System.
Another major target, he said, was the commitment by Member States to reduce deaths associated with bacterial AMR by 10 per cent by 2030, compared with the 2019 baseline.
Samson stressed that countries must also be supported to secure catalytic funding and strengthen implementation of their multisectoral national action plans.
The animal health dimension of the crisis, according to WOAH, is equally critical, with preventable infections in livestock and other animals contributing to antimicrobial use and the wider resistance problem.
Dr Jane Lwoyero, Programme Officer, WOAH, said prevention, vaccination, surveillance, cross-sectoral coordination and sustainable financing were central to the organisation's strategy for reducing antimicrobial use in animals.
She disclosed that animal diseases account for losses estimated at up to $300 billion annually, much of which could be reduced through preventive measures, including vaccination, farm biosecurity, early detection and rapid response.
Despite the importance of vaccination, Lwoyero said fewer than 20 per cent of WOAH Member Countries vaccinate animals against notifiable diseases.
She said WOAH had established an ad hoc animal health group, PROEVA, to identify priority animal diseases for which vaccines could reduce the need for antibiotics in pigs, poultry and fish.
The organisation had also established the PREVENT Forum, a public-private platform designed to address barriers to vaccination, including regulatory challenges, affordability, access, equity and the development of national vaccination strategies.
On antimicrobial consumption, Lwoyero disclosed that previous WOAH ANIMUSE reports showed a three per cent reduction in global antimicrobial use in animals between 2019 and 2024.
However, she warned that the continued use of antibiotics for growth promotion remained a major concern.
According to her, countries that permit the practice tend to use 45 per cent more antimicrobials than those that do not.
“74% countries do not use antimicrobial growth promoters, 19% report using them, and 7% do not report but are still unknown regarding using antimicrobials for growth promotion,” she said.
Lwoyero said WOAH was encouraging countries to discontinue the practice, stressing that antibiotics should not be used to compensate for poor animal husbandry, inadequate farm hygiene or weak disease prevention.
She said: “We need also to commit to using antimicrobials in animals prudently and responsibly. This also goes hand-in-hand with vaccination strategies, farm biosecurity strengthening, good animal husbandry practices, because all these work together to reduce the need for antimicrobials — and when we need them, then let’s use them prudently and responsibly.”
She also called for greater investment in veterinary services, describing chronic underfunding of animal health systems as a major obstacle to containing AMR.
Citing WOAH findings, she said every dollar invested in preventing animal diseases and strengthening animal health systems could generate a return of $28.
“This will reduce the need for antimicrobials while protecting livelihoods and public health,” she said.
Lwoyero warned that the human health consequences of AMR could not be separated from what happens on farms, in food production systems and in the environment.
“When we protect human health, it does not only start when they are at the clinic. This protection starts with stronger animal health systems, because these assure us that the animals will be healthy, the food from these animals will be healthy, and therefore people interacting with the animals and with the food from the animals will also be healthy.”
She further called for increased contributions to the AMR Multi-Partner Trust Fund, which she said had been instrumental in helping countries scale up implementation of their national action plans.
Meanwhile, Chairperson of the Global AMR Media Alliance (GAMA), Shobha Shukla, said the threat of drug resistance was much closer to everyday life than many people realised.
She warned that seemingly minor injuries, including cuts and needle pricks, could expose people to drug-resistant infections that may be difficult or even impossible to treat.
“A simple injury – a cut or a needle prick or any other such day-to-day accident - can put us at risk of getting infected with drug-resistant infections – which could be difficult to treat due to AMR or worse – incurable.
“This could happen to our lovely plants and animals too – and is polluting our environment – our mother Earth too. We need to save the medicines that protect us. We are talking about antibiotics, antifungals, antivirals and antiparasitics or other medicines. We need to stop misuse and overuse of medicines that fuels antimicrobial resistance. And most importantly, we need to ensure no one gets infected with preventable infectious diseases.”
Shukla said the 2026 World AMR Awareness Week, observed globally from November 18 to 24, was themed: “One Health, one action: Prevent AMR now.”
She noted that AMR remained among the world's top 10 global health threats and posed a serious danger to food security, adding that the priority must shift from simply encouraging countries to develop national action plans to ensuring they have the capacity to implement them.
“The central challenge is no longer simply getting countries to recognise AMR or develop national action plans. It is ensuring that countries have the funding, surveillance systems, laboratory capacity, effective interventions and accountability mechanisms to implement them.”
According to her, the updated Global Action Plan offers an opportunity to strengthen prevention-first interventions, promote sustainable agrifood systems, address environmental drivers of resistance and improve national accountability.
However, she cautioned that efforts to curb inappropriate antimicrobial use must not deprive patients who genuinely need these medicines of access to effective treatment.
“Countries responses must balance preventing unnecessary antimicrobial use while ensuring people who genuinely need effective medicines can obtain them. A multi-sectoral response under the One Health banner is warranted to prevent AMR. Equally important is to humanize AMR response at all levels in a person-centred, rights-based and gender transformative manner.”
The experts agreed that the success of the new global action plan would ultimately depend on whether governments backed their commitments with sustained financing, functional surveillance systems, accessible diagnostics and coordinated action across human, animal, agricultural and environmental health.
For countries such as Nigeria, hosting the Fifth Global High-Level Ministerial Conference on AMR presents an opportunity to move the conversation beyond declarations and establish concrete national priorities, financing commitments and accountability mechanisms for implementation.
The message from the experts is clear: preventing infections, protecting the effectiveness of existing medicines and strengthening health systems must happen together. The cost of delaying action will extend far beyond hospitals, reaching farms, food systems, households and the wider environment.
The message from the experts is that antimicrobial resistance cannot be contained by hospitals, doctors or pharmaceutical regulation alone. It requires action across farms, food production systems, industries, communities and government institutions.
With the Abuja ministerial conference approaching, the challenge for governments is increasingly clear: translate global commitments into funded national programmes, enforce existing regulations and make prevention a priority before drug-resistant infections become even harder to treat.
No comments:
Post a Comment